Lineage Cell Therapeutics In shares owned by Vanguard Group
Quarter-by-quarter ownership of Lineage Cell Therapeutics In (LCTX) shares owned by Vanguard Group
from 13F filings
Historical chart of Vanguard Group investment in Lineage Cell Therapeutics In
Tip: Access up to 7 years of quarterly data
All positions including Lineage Cell Therapeutics In held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Lineage Cell Therapeutics In by Vanguard Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $15M | 9.0M | 1.69 |
| 2025-06-30 | $7.7M | 8.5M | 0.91 |
| 2025-03-31 | $4.0M | 8.9M | 0.45 |
| 2024-12-31 | $4.3M | 8.6M | 0.50 |
| 2024-09-30 | $7.8M | 8.6M | 0.91 |
| 2024-06-30 | $8.5M | 8.5M | 1.00 |
| 2024-03-31 | $12M | 8.4M | 1.48 |
| 2023-12-31 | $9.1M | 8.4M | 1.09 |
| 2023-09-30 | $9.8M | 8.3M | 1.18 |
| 2023-06-30 | $10M | 7.2M | 1.41 |
| 2023-03-31 | $9.8M | 6.5M | 1.50 |
| 2022-12-31 | $7.1M | 6.1M | 1.17 |
| 2022-06-30 | $9.4M | 6.0M | 1.58 |
| 2022-03-31 | $9.2M | 6.0M | 1.54 |
| 2021-09-30 | $15M | 6.0M | 2.52 |
| 2021-06-30 | $18M | 6.4M | 2.85 |
| 2021-03-31 | $13M | 5.6M | 2.34 |
| 2020-12-31 | $11M | 6.2M | 1.77 |
| 2020-09-30 | $4.9M | 5.2M | 0.94 |
| 2020-06-30 | $4.5M | 5.2M | 0.86 |
| 2020-03-31 | $4.5M | 5.5M | 0.83 |
| 2019-12-31 | $4.9M | 5.5M | 0.89 |
| 2019-09-30 | $5.4M | 5.5M | 0.98 |